Latest filing published 03 Aug 2023 for Catalent, Inc..
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Karen Murphy Santiago: trading record in brief
This profile gathers the share dealings of Karen Murphy Santiago across 2 companies, led by Bristol Myers Squibb Co and Catalent, Inc. Over a trading history stretching from 10 March 2018 to 1 August 2023, the count stands at 88 filings.
On the market, this insider has only sold: 2 sales, €547k in total. The rest of the record consists of 33 share grants and 30 option exercises.
On 3 August 2023 came the latest disclosure, a share grant in Catalent, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Karen Murphy Santiago
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,342 shares0Common StockSEC:0001596783-23-000076:0
- 740 shares0Common StockSEC:0001596783-22-000150:0
- 6,577 shares@ US$69.195100.0% of flowCommon Stock, $0.10 par valueSEC:0000014272-22-000088:0
- 683 shares0Common Stock, $0.10 par valueSEC:0000014272-22-000071:0
- 1,069 shares0Common Stock, $0.10 par valueSEC:0000014272-21-000181:0
5 of 5 declarations
